| Title |
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, February 2019
|
| DOI | 10.1007/s00262-019-02307-x |
| Pubmed ID | |
| Authors |
Linh T. Nguyen, Samuel D. Saibil, Valentin Sotov, Michael X. Le, Leila Khoja, Danny Ghazarian, Luisa Bonilla, Habeeb Majeed, David Hogg, Anthony M. Joshua, Michael Crump, Norman Franke, Anna Spreafico, Aaron Hansen, Ayman Al-Habeeb, Wey Leong, Alexandra Easson, Michael Reedijk, David P. Goldstein, David McCready, Kazuhiro Yasufuku, Thomas Waddell, Marcelo Cypel, Andrew Pierre, Bianzheng Zhang, Sarah Boross-Harmer, Jane Cipollone, Megan Nelles, Elizabeth Scheid, Michael Fyrsta, Charlotte S. Lo, Jessica Nie, Jennifer Y. Yam, Pei Hua Yen, Diana Gray, Vinicius Motta, Alisha R. Elford, Stephanie DeLuca, Lisa Wang, Stephanie Effendi, Ragitha Ellenchery, Naoto Hirano, Pamela S. Ohashi, Marcus O. Butler |
Mendeley readers
The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 152 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 19 | 13% |
| Student > Bachelor | 18 | 12% |
| Researcher | 17 | 11% |
| Student > Master | 15 | 10% |
| Student > Doctoral Student | 11 | 7% |
| Other | 21 | 14% |
| Unknown | 51 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 19% |
| Biochemistry, Genetics and Molecular Biology | 28 | 18% |
| Immunology and Microbiology | 21 | 14% |
| Agricultural and Biological Sciences | 9 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
| Other | 6 | 4% |
| Unknown | 56 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2023.
All research outputs
#7,753,975
of 23,577,654 outputs
Outputs from Cancer Immunology, Immunotherapy
#1,064
of 2,948 outputs
Outputs of similar age
#164,029
of 448,290 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#7
of 21 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,948 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,290 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.